Aaron Kesselheim in the media

Aaron Kesselheim (2009 Awardee) was interviewed in "Why 'Generic' Doesn't Mean 'Cheap'" on Science Friday, September 25, 2015. He was also quoted in "Fast-Track FDA Approval for Big Drug Companies Might Be a Bad Thing" on Vice News, September 25, 2015. He was quoted in "The drug industry wants us to think Martin Shkreli is a rogue CEO. He isn’t." in The Washington Post, September 25, 2015. Kesselheim was quoted in "21st Century Cures: Safety Concerns About Bayer’s Essure Female Sterility Implant Heighten Just Before Senate Weighs Proposal To Hasten Medical Device Approvals" on International Business Times, September 25, 2015. His research was cited in "D.C. Week: Boehner Shocks Congress With Plans to Resign" on MedPageToday, September 26, 2015. He was quoted in "Why does the U.S. pay more for prescription drugs?" on Fox2Now, September 28, 2015. Kesselheim had research featured in "Two Studies Question FDA’s Fast-Track Review Process" on P&T Community, September 24, 2015.

Date: 
Tuesday, September 29, 2015
Investigator: